Job DescriptionThe Molecular Characterization Laboratory (MoCha) is part of Leidos Biomedical ResearchA cents € (TM) s Clinical Research Directorate (CRD) at the Frederick National Laboratory for Cancer Research. The MoCha Laboratory is responsible for providing high-level research in support of the NCI-Cancer Diagnostics Program (CDP) within the Division of Cancer Treatment and Diagnosis (DCTD). MoCha is charged with the development and application of genomic assays for use in medical research and diagnostics for DCTD-sponsored national extramural clinical trials.KEY ROLES/RESPONSIBILITIESThe Molecular Pathologist will:Support DCTD in their initiative to establish the creation of cutting edge genomic assays used for molecular profiling of patient specimensAssist the MoCha CLIA Director in the review of next generation sequencing (NGS) clinical trial results and sign-off on patient reports; current efforts utilize NGS and gene expression profiling from formalin fixed paraffin embedded specimensRepresent laboratory activities as part of regulatory meetingsIndependently perform clinical duties and function as a collaborator with the Principal Investigators (PI) Oncologists Interact with assay development groups and contribute to efforts to keep technologies current and effectiveProvide medical oversight of clinical evaluations necessary to conduct clinical laboratory studies in support of DCTD/Cancer Therapy Evaluation Program (CTEP) sponsored trialsHave direct involvement in histological interpretation of patient derived xenograft models for an ongoing project under DTCDAuthor document, review pertinent research and clinical protocolsContribute to the development and refinement of protocol approaches and methodsThis position will be located in Frederick, Maryland.Basic Qualifications:To be considered for this position, you must minimally meet the knowledge, skills, and abilities listed below:This is a dual level requisition. It may be filled at either a Physician II or Physician III level. Basic Qualifications for a Physician II:Current professional license in Medicine in a state, Territory, or Commonwealth of the United States, or in the District of ColumbiaWill be required to obtain State of Maryland medical license once offer is acceptedCompletion of medical residency and/or fellowship in applicable specialty areaBoard certified in applicable specialty area or equivalent clinical experienceA minimum of one (1) year of relevant experienceBasic Qualifications for a Physician III:Current professional license in Medicine in a state, Territory, or Commonwealth of the United States, or in the District of ColumbiaWill be required to obtain State of Maryland medical license once offer is acceptedCompletion of medical residency and/or fellowship in applicable specialty areaBoard certified in applicable specialty area or equivalent clinical experienceA minimum of three (3) years of relevant experienceBoth the Physician II and Physician II require:Training/experience in the field of oncology and/or pathologyIn depth understanding of quality metrics data for NGS platformsExperience reviewing results of germline and/or somatic NGS assays for validityExperience Interpreting variants in the context of the medical literature (experience with oncology and germline diagnostics including hereditary cancer syndromes)Experience corresponding with medical geneticists and oncologists on interpretation of resultsProfessional mastery of clinical research concepts and processesKnowledge/experience of molecular assaysExpertise in clinical research protocol implementation and managementAbility to perform genomic analysis using NGS toolsAbility to successfully perform in a highly matrix collaborative teamProven track record of relevant publicationsBackground with federally-regulated research grants, clinical trials or pharmaceutical projectsWorking knowledge of Good Laboratory Practices (GLP) and CMS CLIA regulations (or equivalent regulatory programs, eg CAP)Strong writing skills and ability to author documents including manuscripts for publications, SOPs, clinical protocols, etc.This position is subject to obtaining a Security ClearancePreferred Qualifications:Candidates with these desired skills will be given preferential consideration: Supervisory experienceRegulatory knowledge pertinent to CLIA or FDA guidelines for clinical assaysFamiliarity with patient derived xenograft and pre-clinical drug studiesExcellent communication skills (written and oral)Ability to work effectively in a teamA cents € oriented environmentAbility to identify and solve complex problemsStrong organizational and multitasking skills Company DescriptionLeidos is a global science and technology solutions leader working to solve the worldA cents € (TM) s toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The companyA cents € (TM) s 33,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported pro forma annual revenues of approximately $10 billion for the fiscal year ended January 1, 2016 after giving effect to the recently completed combination of Leidos with Lockheed Martin's Information Systems & Global Solutions business (IS&GS). For more information, visit . The companyA cents € (TM) s diverse employees support vital missions for government and commercial customers. Qualified women, minorities, individuals with disabilities and protected veterans are encouraged to apply. Leidos will consider qualified applicants with criminal histories for employment in accordance with relevant Laws. Leidos is an Equal Opportunity Employer.